TopTier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,397
Closed -$84.7K 198
2026
Q1
$84.7K Buy
+1,397
New +$81.4K 0.05% 186

Other funds holding BMY

TopTier Wealth Management's BMY Position: Q2 2026 in Review

TopTier Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 1,397 shares — an estimated $84.7K sold.

TopTier Wealth Management first reported a position in BMY in Q1 2026 and held it in 1 quarter. The position peaked at $84.7K in Q1 2026. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • TopTier Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • TopTier Wealth Management sold 1,397 Bristol-Myers Squibb shares in Q2 2026, an estimated $84.7K.
  • TopTier Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2026 and held it in 1 quarter.
  • TopTier Wealth Management's Bristol-Myers Squibb position peaked at $84.7K in Q1 2026.
  • 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on TopTier Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.